| Accession Number: | 0001562180-20-003482 |
| Date: | 2020-05-06 |
| Issuer: | BIO-TECHNE CORP (TECH) |
| Original Submission Date: |
WIENS HAROLD J
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-05-06 | M | 4,260 | a | $87.34 | 9,481 | direct | ||
| COMMON STOCK | 2020-05-06 | S | 4,260 | d | $250.00 | 5,221 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 87.34 | 2020-05-06 | deemed execution date | M | 4,260 (d) | 2016-10-29 | 2025-10-28 | common stock 4,260 | $87.34 | 0 | direct | |
| STOCK OPTION (RIGHT TO BUY) | 101.19 | deemed execution date | 0 ( ) | 2017-10-26 | 2026-10-26 | common stock 3,985 | $101.19 | 3,985 | direct | |||
| STOCK OPTION (RIGHT TO BUY) | 125.05 | deemed execution date | 0 ( ) | 2018-10-25 | 2027-10-26 | common stock 3,125 | $125.05 | 3,125 | direct | |||
| STOCK OPTION (RIGHT TO BUY) | 179.84 | deemed execution date | 0 ( ) | 2019-10-24 | 2028-10-25 | common stock 1,898 | $179.84 | 1,898 | direct | |||
| STOCK OPTION (RIGHT TO BUY) | 201.64 | deemed execution date | 0 ( ) | 2029-10-24 | common stock 2,011 | $201.64 | 2,011 | direct |
| ID | footnote |
|---|---|
| f1 | the sale reported in this form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on october 31, 2019. |
| f2 | the option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of bio-techne 2020 annual meeting of shareholders. |
